Related by context. All words. (Click for frequent words.) 73 HuMax TAC 71 TransVax tm 71 Selective Electrochemical Tumor Ablation 71 BiTE R 70 Immunotherapeutic 70 apricitabine ATC 69 PDE4 inhibitor 69 NPC 1C 69 Curaxin 68 developing TB4 68 Allovectin 7 68 MAGE A3 ASCI 68 Maxy G# 68 GVAX ® 68 fusion inhibitor 68 mda 7 68 Personalized Immunotherapy 68 Vaxfectin R formulated 68 mertansine 68 Phase #b/#a clinical 68 non nucleoside inhibitor 68 MVA BN R 68 plasmid DNA pDNA 68 Nanobody 68 TRACON Pharmaceuticals 67 therapeutic monoclonal antibody 67 immunotherapeutic vaccine 67 Scancell 67 human IgG1 monoclonal 67 SynCon 67 immunotherapeutic agent 67 LEAPS TM 67 IMiDs ® 67 GeneICE 67 personalized dendritic 67 oncolytic virus therapies 67 acyclovir Lauriad R 67 Initiates Enrollment 67 visit www.genenews.com 67 Initiate Clinical Trial 67 DPX Survivac 67 SAR# [004] 67 RNA antagonists 67 WILEX 67 Hedgehog antagonist 67 ALTROPANE R 67 IAP inhibitors 67 Onconase 67 delivery polymer matrix 67 trastuzumab DM1 T DM1 67 Nanobody R 67 Submits IND 67 novel therapeutic antibodies 67 targeted radiotherapeutic 67 GVAX R 67 Initiates Phase II 67 novel immunotherapeutic 66 aurora kinase 66 Allovectin 7 R 66 P#X# antagonist 66 Phase Ib IIa 66 systemic RNAi 66 MVA BN ® 66 molecular imaging radiopharmaceutical 66 Initiates Phase III 66 Bioral Amphotericin B 66 immuno therapeutic 66 RhuDex R 66 HuCAL antibodies 66 VitiGam 66 OncoVex 66 5 lipoxygenase activating 66 OMP #R# 66 TRO# 66 NEUGENE R 66 phosphatidylserine PS targeting 66 midstage trials 66 Achieves Primary Endpoint 66 Japanese Encephalitis Vaccine 66 Vaxfectin R adjuvant 66 IMA# 66 isoform selective 66 Chimigen TM 66 MT#/MEDI-# 66 TBC M4 66 Initiates Clinical 66 Therapeutic Vaccine 66 Adjuvanted 66 Archexin 66 OncoVEX 66 RhuDex ® 66 TransVax ™ 66 candidate deforolimus 66 non porcine pancreatic 66 Vaxfectin TM formulated 66 rxRNA 66 anti CD3 monoclonal 66 agonistic human 66 AdVac 66 oral salmon calcitonin 66 telomerase therapeutic 66 Begins Dosing 66 liposomal delivery 66 ddRNAi 66 Factor VIIa 66 LEVADEX ™ 66 Epigenomics proprietary 65 NS5b 65 Vaxfectin 65 FOLOTYN ® 65 AEG# 65 Vaxfectin ® 65 immunotherapeutics 65 Hsp# Inhibitor 65 MVA BN 65 Galenea 65 ATL# [001] 65 cellular immunotherapy 65 maturation inhibitor 65 OvaRex R 65 recombinant biopharmaceutical 65 LHRH antagonist 65 Angiocept 65 Tesetaxel 65 HCV polymerase 65 TransVax 65 Virosome Biologicals 65 volociximab 65 successfully commercialize Iluvien 65 Potelligent Technology 65 CRMD# 65 initiated Phase Ib 65 maturation inhibition 65 FluINsure 65 Aganocide 65 SinuNase ™ 65 aerosolized AAT 65 DermaVir Patch 65 CYT# potent vascular disrupting 65 Phase IIIb clinical 65 Enhanze 65 AAG geldanamycin analog 65 immatics 65 therapeutic monoclonal antibodies 65 Phase IIb clinical trials 65 Phase IIb III 65 adecatumumab MT# 65 Oncotype DX colon cancer 65 HuMax Inflam 65 ALN PCS 65 LymphoStat B TM 65 Entry Inhibitor 65 AtuRNAi 65 attach auristatin 65 Completes Patient Enrollment 65 VitiGam TM 65 Septin9 65 novel VDA molecule 65 THR beta agonist 65 PEGylated interferon 65 ImmunoGen TAP technology 65 InterfeRx 65 IAP inhibitor 65 Aganocide ® 65 GeoVax vaccine 65 intranasal delivery 65 AdVac ® 65 Pertuzumab 65 anticancer therapeutics 65 HDL Selective Delipidation 65 Stapled Peptide 65 recombinant subunit vaccine 65 Kosan dependence 64 Files IND 64 Trastuzumab DM1 64 autologous cellular immunotherapy 64 histone deacetylase HDAC 64 Surfaxin LS 64 Nipent R 64 ZFP Therapeutics 64 Tesmilifene 64 SPL# Gel vaginal microbicide 64 Nasdaq MITI biopharmaceutical 64 GLP toxicology studies 64 prophylactic vaccine 64 TransVax TM 64 NADiA 64 progressive metastatic prostate 64 CEQ# 64 SynCon ™ 64 hyaluronidase enzyme 64 Annamycin 64 huC# DM4 64 cancer immunotherapies 64 drug GAP #B# 64 PGL# 64 antibody MAb 64 Tarvacin TM 64 Cancer Vaccines 64 Awarded Qualifying Therapeutic 64 LentiVector technology 64 tiapamil 64 outlicensed 64 oral PTH 64 Immunotherapeutics 64 potent suppressor 64 prophylactic vaccines 64 novel peptides 64 PNP inhibitor 64 Prodarsan R 64 LungAlert TM 64 Vaccine Adjuvant 64 CCR5 antagonist 64 Phase III TRIST 64 HyperAcute 64 IMiDs R 64 initiated Phase 1b 64 Ixempra 64 Daclizumab 64 Exherin 64 recombinant adeno associated 64 ONCONASE R 64 Neugene 64 Monoclonal antibody 64 Please visit www.antisoma.com 64 Novosom 64 Pfizer Selzentry 64 Cotara ® 64 CMV vaccine 64 IMiDs ® compound 64 Neogenix 64 Panzem 64 biologic therapeutics 64 defensin mimetic antibiotic 64 receptor tyrosine kinase inhibitor 64 Tumour Vascular Disrupting Agent 64 CCR9 antagonist 64 ARRY # 64 therapeutic peptide 64 ASONEP TM 64 vidofludimus 64 CD# CEA 64 Litx 64 taxane derivative 64 Cloretazine ® 64 Locked Nucleic Acid LNA 64 Systemic Delivery 64 GW# [003] 64 Inc. Nasdaq IMGN 64 compound perifosine 64 Maribavir 64 ospemifene 64 TOCOSOL Camptothecin 64 PENNVAX B 64 HDAC Inhibitor 64 molecular chaperone regulation 64 Nasdaq PPHM 64 MedPulser 64 Elagolix 64 lipid nanoparticle 64 small molecule glucokinase 64 EndoTAG TM 64 MorphoSys proprietary 64 humanised monoclonal antibody 64 CytoFabTM 64 OMP #M# 64 SNT MC# 64 Multimeric 64 alvespimycin 64 Temsirolimus 64 MKC# MT 64 PSMA ADC 64 Tech DVAX 64 PDE# 64 TLR7 agonist 64 investigational humanized monoclonal antibody 64 Spiegelmer ® 64 PrevOnco ™ 63 Alnylam Nasdaq ALNY 63 Zalypsis 63 AMEX RGN 63 Crucell PER.C6 63 Onko Sure ™ 63 acetonide FA 63 forodesine 63 VivaGel TM 63 StemEx 63 immunotherapeutic approaches 63 AmpliChip 63 YONDELIS 63 Eligen ® Technology 63 Nasdaq IMGN 63 GRNVAC1 63 Nasdaq HALO 63 Thiovir 63 SUCCEED trial 63 Aviptadil 63 JAK2 inhibitor 63 oral ghrelin agonist 63 Ceflatonin 63 mSEPT9 biomarker 63 Gentamicin Surgical Implant 63 Nanobody ® 63 NASDAQ INFI 63 ZaBeCor 63 dose intramuscular 63 Silodosin 63 Octreolin 63 including eniluracil ADH 63 candidate CRLX# 63 Lung Flute ® 63 PENNVAX ™ B 63 PF # [002] 63 tubulin inhibitor 63 ALN TTR 63 Therapeutic Competitors companiesandmarkets.com adEgemonye 63 Ketotransdel 63 Fodosine 63 ChimeriVax JE 63 Fc fusion protein 63 Panzem R NCD 63 generation URAT1 inhibitor 63 siRNA therapeutics 63 ELACYT 63 DepoVax 63 Valortim TM 63 chimeric monoclonal antibody 63 Presents Preclinical 63 anionic backbone 63 rotavirus shingles 63 TKM PLK1 63 Urocidin 63 Receives Milestone Payment 63 AMD# [002] 63 Successfully Completes Phase 63 HCV RNA polymerase 63 OvaRex ® MAb 63 ALTROPANE 63 introduced NEUGENE 63 developing Zerenex ferric 63 miRNA therapeutics 63 VivaGel ™ 63 Alfacell proprietary ribonuclease 63 Protexia ® 63 ASX PGL 63 Solazed 63 Anavex #-# 63 Initiates Clinical Trial 63 SIX RO ROG 63 LymphoStat B belimumab 63 CA9 SCAN 63 OMAPRO ™ 63 Nasdaq RDEA 63 platinum chemotherapeutic 63 eTag assays 63 omacetaxine mepesuccinate 63 accumulate preferentially 63 HuCAL R 63 selectively inhibit replication 63 DepoVax TM 63 GLPG# 63 NV1FGF 63 HuCNS SC ® 63 Captisol ® 63 EGS# 63 cathepsin K inhibitor 63 phase IIb trial 63 OncoGel 63 registrational trial 63 selective orally bioavailable 63 MKC# MKC# PP 63 Therapeutic Competitors Companies 63 Vegenics 63 TOCOSOL 63 Septin 9 63 MCSP respectively 63 PORxin TM 63 prostone 63 HDL Mimetic Peptide 63 Panzem R 63 deforolimus 63 histone deacetylase HDAC inhibitor 63 Fleximer R 63 NYSE Amex PBTH 63 Romidepsin 63 Receive Milestone Payment 63 Pruvel TM 63 Hematide TM 63 vinorelbine tartrate 63 GRN# 63 selective kinase inhibitor 63 targeting CD# 63 Micromet BiTE 63 candidate REP# 63 Provectus Pharmaceuticals specializes 63 Nasdaq ENZN 63 Phase Ib II 63 Kinase Inhibitor 63 Vitaxin 63 Vascular Wrap TM 63 SuperAntibody 63 LSE ASM 63 Loramyc TM 63 ChronVac C R 63 subsidiaries visit http:/www.apricusbio.com 63 outlicensing 63 please visit www.advaxis.com 63 VIR# 63 Japanese Encephalitis vaccine 63 Pafuramidine 63 StemEx R 63 novel immunomodulatory 63 Insegia 63 Quinamed 63 XmAb 63 BrachySil TM 63 selective estrogen receptor modulator 63 vascular disrupting agent 63 oral prodrug 63 NASDAQ ALNY 63 Rigel R# 63 ZFP Therapeutic 63 potently inhibit 63 candidates Azedra TM 63 evaluating satraplatin 63 romazarit 63 Evoltra ® 63 Breast Cancer Assay 63 Loramyc R 63 Roche OTC RHHBY 63 CVac 63 Synflorix 63 humanized monoclonal antibodies 63 orally inhaled migraine 63 Intravenous Human 63 MOVIPREP R 63 Alnylam #x# 63 Novolimus 63 candidate TNFerade biologic 63 compound ISA# 63 anticoagulant reversing agent 63 BRAF inhibitors 63 fully liquid pentavalent 63 AIMM trial 63 anti CD# monoclonal 63 kidney urologic 62 ZK EPO 62 Molecular Diagnostic Test 62 Vicriviroc 62 anti PlGF 62 tumor vascular disrupting 62 Micromet proprietary BiTE 62 Tuberculosis Vaccine 62 CCR5 mAb 62 NADiA ProsVue 62 induced macular edema 62 Immunotherapies 62 HuCAL GOLD 62 MAXY VII 62 multicenter Phase II 62 MOZOBIL 62 Initiate Phase 62 Reports Preclinical Data 62 reslizumab 62 generation purine nucleoside 62 BHT DNA 62 Fresenius Biotech 62 GVAX cancer 62 virosome 62 NTDDS 62 ChronVac C 62 Excellarate TM 62 Somatuline Autogel 62 IRX 2 62 product candidate Lpathomab 62 Oglemilast 62 LBH# 62 Vascular Disrupting Agent 62 Isis antisense 62 Clevudine 62 biotherapeutic drugs 62 Modified Vaccinia Ankara MVA 62 PANVAC VF 62 Tykerb lapatinib 62 MEK inhibitor 62 Immuron 62 SynCon TM 62 R sorafenib tablets 62 trastuzumab DM1 62 proteasome inhibitor 62 Nasdaq ACHN 62 AB OMXS BINV 62 Bafetinib 62 theranostic 62 phase IIb clinical 62 radiation sensitizer 62 Cx# [002] 62 Prednisone Against Refractory 62 Completes Dosing 62 proprietary electroporation 62 DIFICID ™ 62 Bioral ® 62 nucleotide analogue 62 eniluracil 62 oncolytic 62 Crucell PER.C6 ® 62 Phase 1a clinical 62 non nucleoside HCV 62 recombinant hepatitis B 62 platform HDL Mimetic 62 Listeria vaccine 62 Kamada AAT 62 HuMax EGFr 62 XmAb# 62 Argatroban 62 DermaVir 62 Vaxfectin TM 62 XmAb ® 62 Submits Biologics License Application 62 HQK 62 Inc. AMEX YMI 62 Troxatyl 62 Receives Orphan Drug Designation 62 Epothilones 62 Locked Nucleic Acid 62 Inc. Nasdaq SGXP 62 MIS# 62 triggers apoptosis programmed 62 Nanoemulsion 62 Xcellerated T Cells 62 CysDisplay 62 DOS# 62 Sphingomab 62 inhibit metastasis 62 Activity Assay 62 Phase III Clinical Trial 62 Chimigen 62 acid phosphatase PAP 62 humanized monoclonal 62 dasatinib Sprycel 62 HyACT 62 peptibody 62 JAK#/JAK# inhibitor CYT# 62 Submits Response 62 Homspera TM 62 XL# anticancer compounds 62 protein tyrosine phosphatase 1B 62 mitogen activated ERK kinase 62 Phase 2b Clinical Trial 62 PEG SN# 62 HCV NS5B polymerase 62 DENVax 62 recurrent metastatic ovarian cancer 62 Presents Preclinical Data 62 StromaCel Inc. 62 Onko Sure TM 62 multi kinase inhibitor 62 delipidation 62 Inotek Pharmaceuticals Corporation 62 Antisense Oligonucleotides 62 Brussels THR 62 PentaStaph 62 IL# PE#QQR 62 INS# [001] 62 AeroLEF R 62 evaluating tivozanib 62 SUTENT ® 62 TRIST study 62 ALN HTT 62 Nicotine Conjugate Vaccine 62 BEZ# 62 RNAi Therapeutic 62 Enhanze Technology 62 Mepact 62 TroVax ® 62 CTAP# Capsules 62 DiLA2 Platform 62 HepeX B 62 NASDAQ REGN 62 Orazol 62 NanoCrystal technology 62 cMET 62 DEEP AF 62 Albugon 62 Loramyc ™ 62 Nasdaq HALO biopharmaceutical 62 humanized therapeutic 62 staphylococcal vaccine 62 Ad5FGF 4 62 Prodarsan ® 62 Alternext ALEHT 62 predictive toxicology 62 RECOTHROM ® 62 treats acute lymphoblastic 62 AMPK activators 62 siRNA therapeutic 62 DermTech International 62 tremelimumab 62 PrevOnco 62 ThermoDox ® clinical 62 investigational hepatitis B 62 proprietary PEGylation 62 bardoxolone 62 DCVax 62 Prednisporin 62 ArQule Kinase Inhibitor Platform 62 nucleotide analog 62 personalized immunotherapy 62 Phase Ib study 62 novel immunotherapies 62 Crofelemer budesonide foam 62 laninamivir 62 RNAi Therapeutics 62 Ophthotech 62 Alferon N 62 Biological Therapy 62 investigational integrase inhibitor 62 WILEX AG 62 novel peptide 62 RPL# 62 INTERCEPT red 62 CONBRIZA 62 CCR5 inhibitor 62 PRESEPT 62 RNA interference RNAi therapeutics 62 R#/MEM 62 Inc. www.micromet inc.com 62 glucokinase activator 62 HIV integrase inhibitors 62 oral taxane 62 Apitope 62 TÎ ² 4 62 acadesine 62 gastro intestinal inflammation 62 OraQuick ® 62 OTCBB ADXS 62 CCR5 receptor antagonist 62 Arcelis ™ 62 vinca alkaloid 62 lintuzumab SGN 62 HCV polymerase inhibitors 62 PI3 kinase inhibitors 62 Telatinib 62 tests miRview TM 62 eligen 62 Transfection Reagent 62 Tarvacin 62 TKM Ebola 62 Endotis 62 RAS MAPK pathway 62 oncolytic virus 62 HCV protease inhibitor 62 CompoZr 62 RiVax 62 Oracea TM 62 alpha folate receptor 62 BioNumerik 62 rPA anthrax vaccine 62 Dalbavancin 62 Allovectin 7 r 62 selective androgen receptor modulator 62 oral proteasome inhibitor 62 DCVax R 62 reformulates existing FDA 62 HCD# [002] 62 Inc. OTCBB ALRX 61 pharmacogenomic translational research 61 Electroporation 61 Nexavar sorafenib 61 product AMD# 61 drug conjugate 61 Tarvacin Anti Cancer 61 Altastaph 61 Fleximer 61 Aurexis 61 NurOwn 61 Eniluracil 61 Mesoblast Limited ASX MSB 61 Factor Receptor 61 PORxin TM platforms 61 nucleoside analog 61 Licenses Novel 61 HuMax CD#b 61 Alvesco R 61 assessing T DM1 61 developer Antisoma plc 61 Gamunex C 61 HSP# inhibitor 61 IMC #B 61 BioSante Pharmaceuticals Announces 61 VersaFilm 61 HGS ETR2 61 Anticalin R 61 Aliskiren 61 talactoferrin 61 Provecta TM 61 deCODE AF TM 61 Pandemic Influenza Vaccine 61 Oasmia 61 novel L DOS# 61 Spiegelmer 61 ThermoDox R 61 IMPDH inhibitor 61 DP VPA 61 Zemiva TM 61 AQUA ® 61 vemurafenib 61 Adnectin 61 Inc. NASDAQ AVII 61 metastatic colorectal 61 Cellerant 61 SEQureDx ™ 61 Announces Poster Presentations 61 rALLy clinical trial 61 Aurora kinase inhibitor 61 Epidermal Growth Factor Receptor 61 NASDAQ OSIR 61 targets Galectin receptors 61 systemic RNAi therapeutic 61 LEVADEX TM 61 metaglidasen 61 HuLuc# 61 IMVAMUNE TM 61 Safinamide 61 Aurora Kinase 61 KL4 Surfactant 61 JAK2 Inhibitor 61 Affymetrix microarray technology 61 novel RNAi therapeutics 61 Receives Orphan Drug 61 AFFITOME R 61 NASDAQ CLDX 61 ASONEP 61 Exelixis compounds 61 Adjuvant Treatment 61 antiangiogenesis 61 GV# [001] 61 Saquinavir 61 Virulizin ® 61 Liposomal 61 PROVENGE ® 61 Solazed TM 61 PROGENSA R 61 MBRX 61 UVIDEM 61 sulfonylhydrazine class 61 PI3K/Akt pathway inhibitor 61 p# inhibitor 61 Dicer Substrate Technology 61 oral talactoferrin 61 Aflibercept 61 targeted antifolate 61 EGEN 61 elotuzumab 61 Nasdaq VRTX 61 Juvaris BioTherapeutics 61 SWX RO SWX ROG 61 Canvaxin 61 TLR9 agonist 61 Phase III ADT 61 Provenge prostate cancer 61 highly purified pasteurized 61 RTP #i 61 oncolytic vaccine 61 orally administered inhibitor 61 Novavax VLP vaccine 61 RECOTHROM R 61 thetreatment 61 GSK '# 61 BCR ABL inhibitors 61 Empatic ™ 61 include ColorectAlert TM 61 ALN RSV program 61 Omacetaxine 61 gets USFDA nod 61 Iluvien ® 61 thymidylate synthase TS 61 OncoVEX GM CSF 61 vaccines oncolytic virus 61 Chemokine 61 sirtuin therapeutics 61 Idera Pharmaceuticals 61 Juvaris 61 small molecule tyrosine 61 Eiger BioPharmaceuticals 61 Cogane 61 Viralytics 61 Abstral ® 61 torezolid phosphate 61 Deforolimus 61 Meets Primary Endpoint 61 vivo validation 61 PEGylated Fab fragment 61 Antibody Drug Conjugate 61 Erbitux cetuximab 61 Protexia R 61 TELINTRA R 61 VaxImmune 61 personalized cellular immunotherapy 61 pralatrexate injection folate analogue 61 anti infective treatments 61 HTS assay 61 A3 adenosine receptor 61 GALNS 61 Vaccinex 61 using VIAdel TM 61 Fibrocell Science 61 IgG1 monoclonal antibody 61 StaphVAX R 61 Harry Palmin President 61 NeuroSolutions 61 Integrase Inhibitor 61 adenovector 61 Phase 2a clinical trials 61 vosaroxin 61 Removab 61 oral antiviral 61 OVIT 61 NEUGENE 61 ATG Fresenius S 61 HuMax CD4 61 novel emulsion formulation 61 NASDAQ CGEN announced 61 Intravenous CP 61 EBx ® 61 ribonucleotide reductase clinically validated 61 GeneSightRx 61 TolerRx 61 Azedra 61 candidate XP# 61 Nexavar ® 61 Campath alemtuzumab 61 leading oral taxane 61 M# rationally 61 liposomal formulation 61 monoclonal antibody MAb 61 phase IIa clinical 61 brivanib 61 Vidaza R 61 phase IIb study 61 Thiarabine 61 dotLab System 61 hypoxia activated prodrug 61 novel oral anticoagulant 61 3 registrational trial 61 molecular imaging radiopharmaceuticals 61 AE# vaccine 61 Prima BioMed 61 targeting PCSK9 61 Genotyping Test 61 Panzem ® 61 DNAwithPap Test 61 antisense inhibitors 61 trivalent seasonal influenza 61 humanised antibody 61 NASDAQ OMER 61 Inc Therapeutic Competitors 61 markets Testim ® 61 Tovaxin ® 61 DNA methylation biomarkers 61 Oxytrex TM 61 sirtuin modulators 61 CytoFab 61 Epeius Biotechnologies Corporation 61 RNAi therapeutic targeting 61 incyclinide 61 phase IIa 61 Nasdaq ALNY 61 investigational oral hepatitis C 61 Lipoxen 61 BCR ABL inhibitor 61 selective S#P# receptor agonist 61 GAP #B# 61 Granted Orphan Drug 61 Phase IIb trials 61 Nasdaq ISIS 61 TBC# 61 topical dermatology 61 ALN TTR# 61 Raf kinase inhibitor 61 proprietary BiTE ® 61 adrenergic regulation 61 VeraTag 61 Pralatrexate 61 Abiraterone acetate 61 miconazole Lauriad 61 Targeted Chemotherapy 61 GTC recombinant form 61 subsidiary Cira Biosciences 61 pDNA vaccine 61 androgen receptor antagonist 61 recombinant PSMA vaccine 61 Oral Calcitonin 61 IG HCR ;) CO 61 TPI ASM8 61 Ingenuity Pathways Analysis 61 NASDAQ AVII developer 61 HepaGam B 61 MyVax R 61 PNT# 61 OTCBB HXBM developer 61 Shire BioChem Inc. 61 Phase lll 61 investigational therapies 61 antiangiogenesis therapies 61 Nasdaq CLDX 61 Bioral 61 SAR# [002] 61 RenaZorb TM 61 Onalta ™ 61 AVAX AC Vaccine 61 small molecule thrombopoietin 61 Squalamine 61 Inc. NASDAQ BPAX 61 H#N# VLP vaccine 61 include Altastaph TM 61 Elvitegravir 61 ritonavir boosted danoprevir 61 Pruvel ™ 61 Nasdaq XTLB 61 c Raf kinase 61 Alnylam RNAi 61 MAXY alpha 61 Nivestim 61 Syntonix 61 MAXY G# 61 SUVN 61 ProtAffin 61 CCR5 inhibitors 61 Inc. OTCBB MBCI 61 programs visit http:/www.bionovo.com 61 Soliris eculizumab 61 midstage clinical 61 Trovax 61 XOMA 3AB 61 Simulect 61 Davanat 61 Biolimus A9 61 Exosome 61 GIPET 61 KuDOS 61 Quark Pharmaceuticals 61 Trubion Pharma 61 novel histone deacetylase 61 Civacir 61 antisense drug 61 Polyphenon ® E 61 UltiMAb ® 61 virus HCV protease inhibitor 61 Aplidin 61 using Crucell PER.C6 61 Helinx technology 61 SNALP 61 RONDEL ™ 61 Sapacitabine 61 LEUKINE 61 selective immunoproteasome inhibitor 61 dimebon latrepirdine 61 ViroChem 61 Unit Dose Budesonide 61 Bevasiranib 61 SGLT Inhibitors 61 Adenosine Therapeutics 61 Campath ® 61 EBx 61 Rosetta Genomics Nasdaq ROSG 61 UPLYSO 61 Talabostat 61 PREVENAR 61 Blinatumomab 61 TMC# [002] 61 PDX pralatrexate 61 Panzem NCD 61 BTG plc 60 recombinant influenza 60 adult mesenchymal stem 60 PhG alpha 1 60 Certican 60 Paris IPN Euronext 60 blood clot dissolver 60 PER.C6 ® production 60 Bicifadine 60 Preclinical studies suggest 60 oral picoplatin 60 antibody MT# 60 VentiRx 60 endothelin antagonist 60 NEUGENE antisense 60 coronary stent merged 60 5 HT3 antagonist 60 TOCOSOL R 60 ImmunoCellular Therapeutics 60 DNA plasmids 60 Omigard TM 60 oral Janus kinase 60 ARIKACE ™ 60 intranasal formulation 60 Inc. Nasdaq ATHX 60 NYSE Amex RGN